Exhibit 107
Calculation of Filing Fee Tables
Form S-3
Ernexa Therapeutics Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| Security | Security Class | Amount | Proposed Maximum Aggregate Offering Price Per | Fee Calculation | Maximum Aggregate Offering | Fee | Amount of Registration | |||||||||||||||||||||
| Type | Title | Registered(1) | Share(2) | Rule | Price | Rate | Fee | |||||||||||||||||||||
| Fees to Be Paid | Equity | Common Stock underlying Pre-funded Warrants Issued to Selling Stockholders | 509,736 | $ | 0.185 | 457(c) | $ | 94,301.16 | 0.0001531 | $ | 14.44 | |||||||||||||||||
| Fees to Be Paid | Equity | Common Stock issued to Selling Stockholders | 9,934,016 | $ | 0.185 | 457(c) | $ | 1,837,792.96 | 0.0001531 | $ | 281.37 | |||||||||||||||||
| Total Offering Amounts | 10,443,752 | $ | 0.185 | 457(c) | $ | 1,932,094.12 | 0.0001531 | $ | 295.80 | |||||||||||||||||||
| Total Fees Previously Paid | - | - | ||||||||||||||||||||||||||
| Total Fee Offsets | - | - | ||||||||||||||||||||||||||
| Net Fee Due | $ | 295.80 | ||||||||||||||||||||||||||
(1)
(2) |
Represents shares offered by the selling stockholders. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), the shares of common stock being registered hereunder include such indeterminate number of shares as may be issuable as a result of stock splits, stock dividends or similar transactions. |
| Estimated solely for the purpose of calculating the registration fee and is based on the average of the high and low sales prices of the registrant’s common stock of $0.185 per share on April 10, 2025 as reported on The Nasdaq Capital Market, pursuant to Rule 457(c) under the Securities Act. |